Immune cell-based screening assay for response to anticancer agents: applications in pharmacogenomics
Amber Frick,1 Yuri Fedoriw,2 Kristy Richards,3,4 Blossom Damania,3,5 Bethany Parks,6 Oscar Suzuki,1 Cristina S Benton,1 Emmanuel Chan,1 Russell S Thomas,7 Tim Wiltshire1,3 1Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, 2Department of Pathology and Laboratory...
Saved in:
Main Authors: | Frick A (Author), Fedoriw Y (Author), Richards K (Author), Damania B (Author), Parks B (Author), Suzuki O (Author), Benton CS (Author), Chan E (Author), Thomas RS (Author), Wiltshire T (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identifying genes that mediate anthracyline toxicity in immune cells
by: Amber eFrick, et al.
Published: (2015) -
Implementing Clinical Pharmacogenomics in the Classroom: Student Pharmacist Impressions of an Educational Intervention Including Personal Genotyping
by: Amber Frick, et al.
Published: (2018) -
Transitioning pharmacogenomics into the clinical setting: training future pharmacists
by: Amber Frick, et al.
Published: (2016) -
Anticancer drug screening: standardization of in vitro wound healing assay
by: Vitor M. Almeida, et al.
Published: (2020) -
Assessment of Pharmacogenomic Panel Assay for Prediction of Taxane Toxicities: Preliminary Results
by: Raffaele Di Francia, et al.
Published: (2017)